Mutation analysis reveals novel and known mutations in SAG gene in first two Egyptian families with Oguchi disease
Tóm tắt
Oguchi disease is a rare type of congenital stationary night blindness associated with an abnormal fundus appearance. It is inherited in an autosomal recessive manner where two types exist according to the gene affected; type 1 associated with S-antigen (SAG) gene mutations and type 2 associated with rhodopsin kinase (GRK1) gene mutations. The aim of this work was to describe the clinical and genetic findings of the first two reported families of Oguchi disease in Egypt and African region. Four members of two consanguineous Egyptian families with history of night blindness since childhood underwent complete ophthalmological examination, standard automated static perimetry, fundus color photography, fundus autofluorescence (FAF), fundus fluorescein angiography (FFA) in light-adapted state and spectral-domain optical coherence tomography (SD-OCT) of both the macula and the optic nerve head as well as central corneal thickness with repeated fundus photography following prolonged dark adaptation. Mutation screening of 7 coding exons of GRK1 gene and 15 coding exons of SAG gene as well as some flanking regions were performed using Sanger sequencing technique. The variants were tested for pathogenicity using different in silico functional analysis tools. The clinical examination and investigations confirmed Oguchi disease phenotype. One patient showed p.R193* (c.577C > T) which is a previously reported SAG gene mutation in a homozygous form. The other three patients from a different family showed (c.649–1 G > C), a novel canonical splice site SAG gene mutation in a homozygous form. The identification of the novel canonical splice site SAG gene variant in three members of the same family with clinically confirmed Oguchi disease reinforces its pathogenicity. A fourth patient from another family carried a previously reported mutation in the same gene. SAG gene variants may be the underlying genetic cause for Oguchi disease in Egypt. Our findings have expanded the spectrum of Oguchi disease-associated mutations in SAG gene and may serve as a basis for genetic diagnosis for Oguchi disease.
Tài liệu tham khảo
Fuchs S, Nakazawa M, Maw M, Tamai M, Oguchi Y, Gal A. A homozygous 1-base pair deletion in the arrestin gene is a frequent cause of Oguchi disease in Japanese. Nat Genet. 1995;10(3):360–2.
Yamamoto S, Sippel KC, Berson EL, Dryja TP. Defects in the rhodopsin kinase gene in the Oguchi form of stationary night blindness. Nat Genet. 1997;15(2):175–8.
Khani SC, Abitbol M, Yamamoto S, Maravic-Magovcevic I, Dryja TP. Characterization and chromosomal localization of the gene for human rhodopsin kinase. Genomics. 1996;35(3):571–6.
Ohguro H, Van Hooser JP, Milam AH, Palczewski K. Rhodopsin phosphorylation and dephosphorylation in vivo. J Biol Chem. 1995;270(24):14259–62.
Hayashi T, Gekka T, Takeuchi T, Goto-Omoto S, Kitahara K. A novel homozygous GRK1 mutation (P391H) in 2 siblings with Oguchi disease with markedly reduced cone responses. Ophthalmology. 2007;114(1):134–41.
Poulter JA, Gravett MSC, Taylor RL, Fujinami K, De Zaeytijd J, Bellingham J, Rehman AU, Hayashi T, Kondo M, Rehman A, Ansar M, Donelly D, Toomes C, Ali M, UK Inherited Retinal Disease Consortium, Genomics England Research Consortium, De Baere E, Leroy BP, Davies NP, Henderson RH, Webster AR, Rivolta C, Zeitz C, Mahroo OA, Arno G, Black GCM, McKibbin M, Harris SA, Khan KN, Inglehearn CF. New variants and in silico analyses in GRK1 associated Oguchi disease. Hum Mutat. 2021;42(2):164–76.
Dryja TP. Molecular genetics of Oguchi disease, fundus albipunctatus, and other forms of stationary night blindness: LVII Edward Jackson Memorial Lecture. Am J Ophthalmol. 2000;130(5):547–63.
Stenson PD, Mort M, Ball EV, Shaw K, Philips AD, Cooper DN. The Human Gene Mutation Database (HGMD®): 2003 Update. Hum Mutat. 2003;21:577–81.
Usui T, Ichibe M, Ueki S, Takagi M, Hasegawa S, Abe H, Sekiya K, Nakazawa M. Mizuo phenomenon observed by scanning laser ophthalmoscopy in a patient with Oguchi disease. Am J Ophthalmol. 2000;130(3):359–61.
Boissonnot M, Robert MF, Gilbert-Dussardier B, Dighiero P. Syndrome d’Oguchi ou cécité nocturne congénitale stationnaire: à propos d’un cas [Oguchi disease or stationary congenital night blindness: a case report]. J Fr Ophtalmol. 2007;30(1):e2.
Colombo L, Abeshi A, Maltese PE, Frecer V, Miertuš J, Cerra D, Bertelli M, Rossetti L. Oguchi type I caused by a homozygous missense variation in the SAG gene. Eur J Med Genet. 2019;62(9):103548.
Mucciolo DP, Sodi A, Murro V, Passerini I, Palchetti S, Pelo E, Virgili G, Rizzo S. A novel GRK1 mutation in an Italian patient with Oguchi disease. Ophthalmic Genet. 2018;39(1):137–8.
Skorczyk-Werner A, Kociecki J, Wawrocka A, Wicher K, Krawczyniski MR. The first case of Oguchi disease, type 2 in a Polish patient with confirmed GRK1 gene mutation. Klin Oczna. 2015;117(1):27–30.
Teke MY, Citirik M, Kabacam S, Demircan S, Alikasifoglu M. A novel missense mutation of the GRK1 gene in Oguchi disease. Mol Med Rep. 2016;14(4):3129–33.
Huang L, Li W, Tang W, Zhu X, Ou-Yang P, Lu G. A Chinese family with Oguchi’s disease due to compound heterozygosity including a novel deletion in the arrestin gene. Mol Vis. 2012;18:528–36.
Maw M, Kumaramanickavel G, Kar B, John S, Bridges R, Denton M. Two Indian siblings with Oguchi disease are homozygous for an arrestin mutation encoding premature termination. Hum Mutat. 1998;Suppl 1:S317-9.
Waheed NK, Qavi AH, Malik SN, Maria M, Riaz M, Cremers FPM, Azam M, Qamar R. A nonsense mutation in S-antigen (p.Glu306*) causes Oguchi disease. Mol Vis. 2012;18:1253–9.
Azam M, Collin RW, Khan MI, Shah STA, Qureshi N, Ajmal M, den Hollander AI, Qamar R, Cremers FPM. A novel mutation in GRK1 causes Oguchi disease in a consanguineous Pakistani family. Mol Vis. 2009;15:1788–93.
Aryan H, Bahadori A, Farhud DD, Zarif Yeganeh M, Pourkalhor H. A homozygote mutation in S-antigen visual arrestin SAG gene in an Iranian patient with Oguchi type one: a case report. Iran J Public Health. 2020;49(5):995–1000.
Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215.
Liu X, Gao L, Wang G, Long Y, Ren J, Fujinami K, Meng X, Li S. Oguchi disease caused by a homozygous novel SAG splicing alteration associated with the multiple evanescent white dot syndrome: a 15-month follow-up. Doc Ophthalmol. 2020;141(3):217–26.
Oishi A, Akimoto M, Kawagoe N, Mandai M, Takahashi M, Yoshimura N. Novel mutations in the GRK1 gene in Japanese patients With Oguchi disease. Am J Ophthalmol. 2007;144(3):475–7.
Sergouniotis PI, Davidson AE, Sehmi K, Webster AR, Robson AG, Moore AT. Mizuo-Nakamura phenomenon in Oguchi disease due to a homozygous nonsense mutation in the SAG gene. Eye. 2011;25(8):1098–101.
Nishiguchi KM, Ikeda Y, Fujita K, Kunikata H, Akiho M, Hashimoto K, Hosono K, Kurata K, Koyanagi Y, Akiyama M, Suzuki T, Kawasaki R, Wada Y, Hotta Y, Sonoda KH, Murakami A, Nakazawa M, Nakazawa T, Abe T. Phenotypic features of Oguchi disease and retinitis pigmentosa in patients with s-antigen mutations: a long-term follow-up study. Ophthalmology. 2019;126(11):1557–66.
Nishiguchi KM, Oguchi Y, Nakazawa T. Progression from classical Oguchi disease to retinitis pigmentosa after 50 years. Ophthalmology. 2020;127(1):51.
Cideciyan AV, Zhao X, Nielsen L, Khani SC, Jacobson SG, Palczewski K. Null mutation in the rhodopsin kinase gene slows recovery kinetics of rod and cone phototransduction in man. Proc Natl Acad Sci U S A. 1998;95(1):328–33.
Nakamura M, Yamamoto S, Okada M, Ito S, Tano Y, Miyake Y. Novel mutations in the arrestin gene and associated clinical features in Japanese patients with Oguchi’s disease. Ophthalmology. 2004;111(7):1410–4.
Ohno K, Takeda JI, Masuda A. Rules and tools to predict the splicing effects of exonic and intronic mutations. Wiley Interdiscip Rev RNA. 2018;9(1):e1451.
Baralle D, Buratti E. RNA splicing in human disease and in the clinic. Clin Sci. 2017;131(5):355–68.
Wimmer K, Schamschula E, Wernstedt A, Traunfellner P, Amberger A, Zschocke J, Kroisel P, Chen Y, Callens T, Messiaen L. AG-exclusion zone revisited: Lessons to learn from 91 intronic NF1 3’ splice site mutations outside the canonical AG-dinucleotides. Hum Mutat. 2020;41(6):1145–56.
Hirsch JA, Schubert C, Gurevich VV, Sigler PB. The 2.8 A crystal structure of visual arrestin: a model for arrestin’s regulation. Cell. 1999;97(2):257–69.
Lally CC, Bauer B, Selent J, Sommer ME. C-edge loops of arrestin function as a membrane anchor. Nat Commun. 2017;8:14258.
Deng Z, Fan F, Tang D, Wu Y, Shu Y, Wu K. A compound heterozygous mutation in the S-Antigen Visual Arrestin SAG gene in a Chinese patient with Oguchi type one: a case report. BMC Ophthalmol. 2022;22(1):99.